Skip to contentSkip to footer
Catalyst Health Ventures
Catalyst Health Ventures
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
1 800 458 56 97
Investor Portal
Catalyst Health Ventures
Investor Portal
Close
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
linkedin
Get in Touch
info@chv.vc
Our Address
129 South Street, 4th Floor,
Boston, MA 02111
Investor Portal
Sera PrognosticsNovember 18, 2019

New Scientific Publication Shows Sera Prognostics Is Leader in Assessing Preterm Birth Risk

Sera PrognosticsJune 24, 2020

Sera Prognostics Appoints Thomas J. Garite, M.D. as Vice President of Clinical Sciences

Sera PrognosticsJune 4, 2020

Sera Publishes Data Showing PreTRM Test Can Predict Delivery Prior to 32 Weeks

Sera PrognosticsMay 28, 2020

Sera Prognostics’ PreTrm Biomarker Test Predicts Adverse Pregnancy Outcomes

Sera PrognosticsMay 28, 2020

Performance of a Proteomic Preterm Delivery Predictor in a Large Independent Prospective Cohort

Posts pagination

<Page 1Page 2Page 3
Catalyst Health Ventures
Catalyst Health Ventures (CHV) is a venture capital firm investing in transformative medical technologies addressing global unmet needs.
Office

129 South Street, 4th Floor,
Boston, MA 02111

info@chv.vc

Links
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
Get In Touch
  • LinkedIn

© 2026 Catalyst Health Ventures. All Rights Reserved | Site By ConvyLab